Andrew Wang, MD
Radiation Oncology · Chapel Hill, NCNPI 1306023460
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $110,903 of the $117,930 with a category attached, or 94.0%. 21 manufacturers reported payments, led by Astrazeneca UK Limited at 43.2% of the total. 2025 is the largest year on record at $57,730, more than ten times the $16 reported in 2019. Among radiation oncology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $1403.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$51K
- Archimmune Therapeutics Inc.$42K
- AstraZeneca$10K
- Beigene USA, Inc.$5K
- AbbVie$5K
- Pfizer$1K
- plus $3K from 15 others
Across 12 payments — averaging $12,704 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Varian Medical Systems, Inc.$70K
- Siemens Medical Solutions USA, Inc.$37K
- Beone Medicines Ltd.$23K
- Eli Lilly$21K
- Beigene, Ltd.$2K
Across 3 payments — averaging $0.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Archimmune Therapeutics Inc.$0
What the payments were for
- Consulting fees$110,90394%
- Travel & lodging$2,3202%
- Food & beverage$4,6264%
- Education$800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 11 | $50,925 |
| Archimmune Therapeutics Inc. | 7 | $42,143 |
| AstraZeneca | 12 | $10,407 |
| Beigene USA, Inc. | 5 | $5,302 |
| AbbVie | 5 | $5,146 |
| Pfizer | 10 | $1,052 |
| Exelixis Inc. | 5 | $808 |
| Johnson & Johnson(2 entities) | 4 | $388 |
| Abbott | 3 | $240 |
| GE HealthCare | 6 | $217 |
| Janssen Scientific Affairs, LLC | 4 | $200 |
| Dendreon Pharmaceuticals LLC | 1 | $160 |
| Boston Scientific | 1 | $147 |
| Seagen Inc. | 2 | $138 |
| Clovis Oncology, Inc. | 1 | $133 |
| Eisai Inc. | 2 | $131 |
| Myovant Sciences Inc. | 1 | $122 |
| Progenics Pharmaceuticals, Inc. | 1 | $107 |
| Eli Lilly | 1 | $105 |
| Novartis | 1 | $31 |
| Telix Pharmaceuticals | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$117,930 in reported general payments places this provider in the 95th percentile of 199 radiation oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 30 | $421 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Chapel Hill
- Joel TepperChapel Hill$22K
- Brandon MullinsChapel Hill$8K
- Colette ShenChapel Hill$6K
- Shivani SudChapel Hill$3K
- Dana CaseyChapel Hill$2K
- Ashley WeinerChapel Hill$2K
- Shekinah ElmoreChapel Hill$1K
- Volker StieberWinston Salem$99K
- Lewis SulmanDurham$54K
- Michael PapagikosWilmington$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.